22157.jpg
DNA Damage Response (DDR) Drugs in Oncology Analytical Tool 2022: The Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer
July 26, 2022 04:43 ET | Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. DNA Damage Response (DDR)...
22157.jpg
Epigenetic Therapies in Oncology Analytical Tool 2022: The Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer
July 22, 2022 04:08 ET | Research and Markets
Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Epigenetic Therapies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. In cancer, many aspects of the...
Florida Cancer Specialists & Research Institute Introduces New In-House Precision Oncology Capabilities
Florida Cancer Specialists & Research Institute Furthers Commitment to Clinical Research & Innovation, Next Generation Sequencing in Advancement of Cancer Care; Adds New In-House, Precision Oncology Capabilities
July 21, 2022 10:13 ET | Florida Cancer Specialists & Research Institute
Fort Myers, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) today announced the formation of additional precision oncology capabilities and...
22157.jpg
Extracellular Vesicles 2022: Two Day Conference - Biology, Disease & Medicine (Washington, United States - September 13-14, 2022)
July 06, 2022 04:08 ET | Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles 2022: Biology, Disease & Medicine" conference has been added to ResearchAndMarkets.com's offering. The host is pleased to...
GENE logo.png
GeneType Risk Assessment Test onboarding in 16 clinics
July 01, 2022 08:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Global Carrier Screening Market
The Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030
June 29, 2022 05:53 ET | Research and Markets
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type; By Medical Condition; By Technology; By End-User; By Regions; Segment...
Global Market for Direct-to-Consumer (DTC) Genetic Testing
Global Direct-to-Consumer (DTC) Genetic Testing Market Report 2022: Market to Reach $1.9 Billion by 2026 - DTC Genetic Testing Presents Lucrative Personalization Opportunities
June 24, 2022 06:53 ET | Research and Markets
Dublin, June 24, 2022 (GLOBE NEWSWIRE) -- The "Direct-to-Consumer (DTC) Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Global Cell Therapy Technologies Market
Global Cell Therapy Technologies Market (2022 to 2031) - Featuring Thermo Fisher Scientific, Merck, MaxCyte and Lonza Group Among Others
June 24, 2022 05:53 ET | Research and Markets
Dublin, June 24, 2022 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Global Market Report 2022, By Product, By Cell Type, By Process, By End User" report has been added to...
Global Gene Therapy Market
$12 Billion Worldwide Gene Therapy Industry to 2031 - Identify Growth Segments for Investment
June 23, 2022 05:38 ET | Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2022, Vector, Application, End Users" report has been added to ResearchAndMarkets.com's offering. This report...
Global Genome Editing Market
Insights on the Genome Editing Global Market to 2027 - Growing Cases of Cancer and Other Genetic Disorders is Driving Growth
June 22, 2022 06:03 ET | Research and Markets
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. Genome editing is a method of making...